370 related articles for article (PubMed ID: 23851196)
1. (-)-Epigallocatechin gallate amplifies interleukin-1-stimulated interleukin-6 synthesis in osteoblast-like MC3T3-E1 cells.
Kuroyanagi G; Otsuka T; Kondo A; Matsushima-Nishiwaki R; Mizutani J; Kozawa O; Tokuda H
Biochimie; 2013 Oct; 95(10):1933-8. PubMed ID: 23851196
[TBL] [Abstract][Full Text] [Related]
2. (-)-Epigallocatechin gallate suppresses endothelin-1-induced interleukin-6 synthesis in osteoblasts: inhibition of p44/p42 MAP kinase activation.
Tokuda H; Takai S; Hanai Y; Matsushima-Nishiwaki R; Hosoi T; Harada A; Ohta T; Kozawa O
FEBS Lett; 2007 Apr; 581(7):1311-6. PubMed ID: 17350626
[TBL] [Abstract][Full Text] [Related]
3. (--)-epigallocatechin gallate enhances prostaglandin F2alpha-induced VEGF synthesis via upregulating SAPK/JNK activation in osteoblasts.
Tokuda H; Takai S; Matsushima-Nishiwaki R; Akamatsu S; Hanai Y; Hosoi T; Harada A; Ohta T; Kozawa O
J Cell Biochem; 2007 Apr; 100(5):1146-53. PubMed ID: 17031857
[TBL] [Abstract][Full Text] [Related]
4. AMPK limits IL-1-stimulated IL-6 synthesis in osteoblasts: involvement of IκB/NF-κB pathway.
Kato K; Tokuda H; Matsushima-Nishiwaki R; Natsume H; Kondo A; Ito Y; Kozawa O; Otsuka T
Cell Signal; 2012 Aug; 24(8):1706-12. PubMed ID: 22560875
[TBL] [Abstract][Full Text] [Related]
5. (-)-Epigallocatechin gallate inhibits thyroid hormone-stimulated osteocalcin synthesis in osteoblasts.
Kato K; Otsuka T; Adachi S; Matsushima-Nishiwaki R; Natsume H; Kozawa O; Tokuda H
Mol Med Rep; 2011; 4(2):297-300. PubMed ID: 21468567
[TBL] [Abstract][Full Text] [Related]
6. (-)-Epigallocatechin gallate inhibits basic fibroblast growth factor-stimulated interleukin-6 synthesis in osteoblasts.
Tokuda H; Takai S; Hanai Y; Matsushima-Nishiwaki R; Yamauchi J; Harada A; Hosoi T; Ohta T; Kozawa O
Horm Metab Res; 2008 Oct; 40(10):674-8. PubMed ID: 18500674
[TBL] [Abstract][Full Text] [Related]
7. (-)-Epigallocatechin gallate reduces platelet-derived growth factor-BB-stimulated interleukin-6 synthesis in osteoblasts: suppression of SAPK/JNK.
Takai S; Matsushima-Nishiwaki R; Adachi S; Natsume H; Minamitani C; Mizutani J; Otsuka T; Tokuda H; Kozawa O
Mediators Inflamm; 2008; 2008():291808. PubMed ID: 19148296
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of SAPK/JNK leads to enhanced IL-1-induced IL-6 synthesis in osteoblasts.
Kondo A; Otsuka T; Matsushima-Nishiwaki R; Kuroyanagi G; Mizutani J; Wada I; Kozawa O; Tokuda H
Arch Biochem Biophys; 2013 Jul; 535(2):227-33. PubMed ID: 23624146
[TBL] [Abstract][Full Text] [Related]
9. (-)-epigallocatechin gallate inhibits prostaglandin D2-stimulated HSP27 induction via suppression of the p44/p42 MAP kinase pathway in osteoblasts.
Yamauchi J; Takai S; Matsushima-Nishiwaki R; Hanai Y; Doi T; Kato H; Ogura S; Kato K; Tokuda H; Kozawa O
Prostaglandins Leukot Essent Fatty Acids; 2007; 77(3-4):173-9. PubMed ID: 17949962
[TBL] [Abstract][Full Text] [Related]
10. Involvement of AMP-activated protein kinase in thrombin-stimulated interleukin 6 synthesis in osteoblasts.
Tokuda H; Kato K; Natsume H; Kondo A; Kuroyanagi G; Matsushima-Nishiwaki R; Ito Y; Otsuka T; Kozawa O
J Mol Endocrinol; 2012 Aug; 49(1):47-55. PubMed ID: 22645249
[TBL] [Abstract][Full Text] [Related]
11. Amplification by (‑)‑epigallocatechin gallate of prostaglandin F2α‑stimulated synthesis of osteoprotegerin in osteoblasts.
Sakai G; Otsuka T; Fujita K; Kainuma S; Kuroyanagi G; Kawabata T; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Mol Med Rep; 2017 Nov; 16(5):6376-6381. PubMed ID: 28849144
[TBL] [Abstract][Full Text] [Related]
12. (-)-Epigallocatechin gallate reduces transforming growth factor beta-stimulated HSP27 induction through the suppression of stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.
Hayashi K; Takai S; Matsushima-Nishiwaki R; Hanai Y; Kato K; Tokuda H; Kozawa O
Life Sci; 2008 May; 82(19-20):1012-7. PubMed ID: 18407296
[TBL] [Abstract][Full Text] [Related]
13. Rho-kinase regulates thrombin-stimulated interleukin-6 synthesis via p38 mitogen-activated protein kinase in osteoblasts.
Kato K; Otsuka T; Matsushima-Nishiwaki R; Natsume H; Kozawa O; Tokuda H
Int J Mol Med; 2011 Oct; 28(4):653-8. PubMed ID: 21750859
[TBL] [Abstract][Full Text] [Related]
14. (-)-Epigallocatechin gallate synergistically potentiates prostaglandin E
Kuroyanagi G; Tokuda H; Yamamoto N; Kainuma S; Fujita K; Ohguchi R; Kawabata T; Sakai G; Matsushima-Nishiwaki R; Harada A; Kozawa O; Otsuka T
Prostaglandins Other Lipid Mediat; 2017 Jan; 128-129():27-33. PubMed ID: 28163121
[TBL] [Abstract][Full Text] [Related]
15. AMP-activated protein kinase inhibitor decreases prostaglandin F2α-stimulated interleukin-6 synthesis through p38 MAP kinase in osteoblasts.
Kondo A; Otsuka T; Kato K; Natsume H; Kuroyanagi G; Mizutani J; Ito Y; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Int J Mol Med; 2012 Dec; 30(6):1487-92. PubMed ID: 23064268
[TBL] [Abstract][Full Text] [Related]
16. Rho-kinase regulates endothelin-1-stimulated IL-6 synthesis via p38 MAP kinase in osteoblasts.
Tokuda H; Hanai Y; Matsushima-Nishiwaki R; Yamauchi J; Doi T; Harada A; Takai S; Kozawa O
Biochem Biophys Res Commun; 2007 Nov; 362(4):799-804. PubMed ID: 17825250
[TBL] [Abstract][Full Text] [Related]
17. Mitogen-activated protein (MAP) kinases are involved in interleukin-1 (IL-1)-induced IL-6 synthesis in osteoblasts: modulation not of p38 MAP kinase, but of p42/p44 MAP kinase by IL-1-activated protein kinase C.
Miwa M; Kozawa O; Tokuda H; Uematsu T
Endocrinology; 1999 Nov; 140(11):5120-5. PubMed ID: 10537140
[TBL] [Abstract][Full Text] [Related]
18. Wnt3a regulates tumor necrosis factor-α-stimulated interleukin-6 release in osteoblasts.
Natsume H; Tokuda H; Adachi S; Matsushima-Nishiwaki R; Kato K; Minamitani C; Otsuka T; Kozawa O
Mol Cell Endocrinol; 2011 Jan; 331(1):66-72. PubMed ID: 20732383
[TBL] [Abstract][Full Text] [Related]
19. Function of Rho-kinase in prostaglandin D2-induced interleukin-6 synthesis in osteoblasts.
Tokuda H; Takai S; Matsushima-Nishiwaki R; Hanai Y; Adachi S; Minamitani C; Mizutani J; Otsuka T; Kozawa O
Prostaglandins Leukot Essent Fatty Acids; 2008; 79(1-2):41-6. PubMed ID: 18771907
[TBL] [Abstract][Full Text] [Related]
20. HSP90 inhibitors potentiate PGF2α-induced IL-6 synthesis via p38 MAP kinase in osteoblasts.
Fujita K; Tokuda H; Kuroyanagi G; Yamamoto N; Kainuma S; Kawabata T; Sakai G; Matsushima-Nishiwaki R; Kozawa O; Otsuka T
PLoS One; 2017; 12(5):e0177878. PubMed ID: 28542188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
